Literature DB >> 9733302

Vestibular schwannoma management in the next century: a radiosurgical perspective.

B E Pollock1, L D Lunsford, G Norén.   

Abstract

PURPOSE: To discuss how the evolution of vestibular schwannoma radiosurgery, changes in health care delivery, and patient accessibility to medical information will affect the management of vestibular schwannomas in the future. CONCEPT: In comparison with microsurgical resection of vestibular schwannomas, radiosurgery has a lower morbidity rate, a similar risk of requiring further surgery, and higher patient satisfaction. As this information becomes more widely available to patients and third-party payors, radiosurgery may replace surgical resection as the preferred management strategy for patients with small to medium sized vestibular schwannomas in the United States. RATIONALE: It is estimated that 2500 patients are diagnosed with vestibular schwannomas each year in the United States. Assuming that 80% undergo surgery, 2000 operations are performed annually for newly diagnosed vestibular schwannomas. Data available since 1987 regarding the number of cases for which gamma knife radiosurgery was performed were used to predict the number of patients who will undergo vestibular schwannoma radiosurgery in the future. If the current trend continues, an equal number of patients will undergo surgical resection and radiosurgery to treat their vestibular schwannomas (approximately 1000/yr) sometime between 2005 and 2010. Moreover, it is predicted that by 2020, two-thirds of the patients who are newly diagnosed with vestibular schwannomas will undergo radiosurgery, with surgical resection being reserved for patients with large tumors associated with symptomatic brain stem compression. DISCUSSION: Early data regarding vestibular schwannoma radiosurgery predicted an exponential growth curve. Although it is premature to assume that the current trend will continue, it is likely that an ever increasing percentage of patients will undergo radiosurgery as accessibility to this alternative increases, and more data are published regarding long-term tumor growth control rates. If the mathematical model proves to be accurate, then stereotactic radiosurgery will replace surgical resection as the preferred management strategy for the majority of patients with vestibular schwannomas.

Entities:  

Mesh:

Year:  1998        PMID: 9733302     DOI: 10.1097/00006123-199809000-00041

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

1.  Functional outcome after gamma knife treatment in vestibular schwannoma.

Authors:  J M Hempel; E Hempel; B Wowra; Ch Schichor; A Muacevic; A Riederer
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-02       Impact factor: 2.503

2.  Prevalence of hydrocephalus in 157 patients with vestibular schwannoma.

Authors:  Jeffrey M Rogg; S H Ahn; G A Tung; S E Reinert; G Norén
Journal:  Neuroradiology       Date:  2005-05-11       Impact factor: 2.804

3.  3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.

Authors:  T Schneider; J Chapiro; M Lin; J F Geschwind; L Kleinberg; D Rigamonti; I Jusué-Torres; A E Marciscano; D M Yousem
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

Review 4.  The evolving role of stereotactic radiosurgery for patients with skull base tumors.

Authors:  Bruce E Pollock; Robert L Foote
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

Review 5.  The changing role of stereotaxis in surgical neuro-oncology.

Authors:  Mark E Linskey
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

6.  Tumor pseudoprogression following radiosurgery for vestibular schwannoma.

Authors:  Caroline Hayhurst; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2011-10-25       Impact factor: 12.300

7.  Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol.

Authors:  O W M Meijer; E J Weijmans; D L Knol; B J Slotman; F Barkhof; W P Vandertop; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-22       Impact factor: 3.825

8.  A Cross-sectional Survey of the North American Skull Base Society: Current Practice Patterns of Vestibular Schwannoma Evaluation and Management in North America.

Authors:  Matthew L Carlson; Jamie J Van Gompel; R Mark Wiet; Nicole M Tombers; Anand K Devaiah; Devyani Lal; Jacques J Morcos; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-03

9.  Inhibition of c-Jun N-terminal kinase activity enhances vestibular schwannoma cell sensitivity to gamma irradiation.

Authors:  Wei Ying Yue; J Jason Clark; Michael Telisak; Marlan R Hansen
Journal:  Neurosurgery       Date:  2013-09       Impact factor: 4.654

Review 10.  Outcomes of stereotactic radiosurgery for large vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Umberto Tosi; Miguel E Tusa Lavieri; Anjile An; Omri Maayan; Sergio W Guadix; Antonio P DeRosa; Paul J Christos; Susan Pannullo; Philip E Stieg; Andrew Brandmaier; Jonathan P S Knisely; Rohan Ramakrishna
Journal:  Neurooncol Pract       Date:  2021-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.